These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effects of sodium intake on the pressor and renal responses to nitric oxide synthesis inhibition in normotensive individuals with different sodium sensitivity. Barba G; Vallance PJ; Strazzullo P; MacAllister RJ J Hypertens; 2000 May; 18(5):615-21. PubMed ID: 10826565 [TBL] [Abstract][Full Text] [Related]
23. Collecting duct-derived endothelin regulates arterial pressure and Na excretion via nitric oxide. Schneider MP; Ge Y; Pollock DM; Pollock JS; Kohan DE Hypertension; 2008 Jun; 51(6):1605-10. PubMed ID: 18391099 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of nitric oxide synthase induces renal xanthine oxidoreductase activity in spontaneously hypertensive rats. Laakso J; Vaskonen T; Mervaala E; Vapaatalo H; Lapatto R Life Sci; 1999; 65(25):2679-85. PubMed ID: 10622277 [TBL] [Abstract][Full Text] [Related]
25. Loss of collectrin, an angiotensin-converting enzyme 2 homolog, uncouples endothelial nitric oxide synthase and causes hypertension and vascular dysfunction. Cechova S; Zeng Q; Billaud M; Mutchler S; Rudy CK; Straub AC; Chi L; Chan FR; Hu J; Griffiths R; Howell NL; Madsen K; Jensen BL; Palmer LA; Carey RM; Sung SS; Malakauskas SM; Isakson BE; Le TH Circulation; 2013 Oct; 128(16):1770-80. PubMed ID: 24048198 [TBL] [Abstract][Full Text] [Related]
26. Asymmetric dimethylarginine: a new player in the pathogenesis of renal disease? Zoccali C; Kielstein JT Curr Opin Nephrol Hypertens; 2006 May; 15(3):314-20. PubMed ID: 16609301 [TBL] [Abstract][Full Text] [Related]
27. Interactions between nitric oxide and renal nerves on pressure-diuresis and natriuresis. Madrid MI; Salom MG; Tornel J; López E; Fenoy FJ J Am Soc Nephrol; 1998 Sep; 9(9):1588-95. PubMed ID: 9727366 [TBL] [Abstract][Full Text] [Related]
28. Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia. Holden DP; Fickling SA; Whitley GS; Nussey SS Am J Obstet Gynecol; 1998 Mar; 178(3):551-6. PubMed ID: 9539525 [TBL] [Abstract][Full Text] [Related]
29. Role of nitric oxide in the evolution of renal ischemia in two-kidney, one-clip renovascular hypertension. Nakamoto H; Ferrario CM; Buckalew VM; Suzuki H Hypertens Res; 1998 Dec; 21(4):267-77. PubMed ID: 9877520 [TBL] [Abstract][Full Text] [Related]
30. The role of intrarenal nitric oxide in the natriuretic response to dopamine-receptor activation. Venkatakrishnan U; Chen C; Lokhandwala MF Clin Exp Hypertens; 2000 Apr; 22(3):309-24. PubMed ID: 10803736 [TBL] [Abstract][Full Text] [Related]
32. Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney disease. Ueda S; Yamagishi S; Kaida Y; Okuda S Nephrology (Carlton); 2007 Dec; 12(6):582-90. PubMed ID: 17995585 [TBL] [Abstract][Full Text] [Related]
33. Deletion of cyclooxygenase-2 in the mouse increases arterial blood pressure with no impairment in renal NO production in response to chronic high salt intake. Stæhr M; Hansen PB; Madsen K; Vanhoutte PM; Nüsing RM; Jensen BL Am J Physiol Regul Integr Comp Physiol; 2013 May; 304(10):R899-907. PubMed ID: 23535462 [TBL] [Abstract][Full Text] [Related]
34. Endothelial nitric oxide synthase enhancer for protection of endothelial function from asymmetric dimethylarginine-induced injury in human internal thoracic artery. Xuan C; Chang FJ; Liu XC; Bai XY; Liao XL; He GW; Ou JS J Thorac Cardiovasc Surg; 2012 Sep; 144(3):697-703. PubMed ID: 22336756 [TBL] [Abstract][Full Text] [Related]
35. Renal effects of acute amino acid infusion in hypertension induced by chronic nitric oxide blockade. Qiu C; Engels K; Samsell L; Baylis C Hypertension; 1995 Jan; 25(1):61-6. PubMed ID: 7843755 [TBL] [Abstract][Full Text] [Related]
36. Nitric oxide protects against ischemic acute renal failure through the suppression of renal endothelin-1 overproduction. Kurata H; Takaoka M; Kubo Y; Katayama T; Tsutsui H; Takayama J; Matsumura Y J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S455-8. PubMed ID: 15838347 [TBL] [Abstract][Full Text] [Related]
37. Nitric oxide and superoxide interactions in the kidney and their implication in the development of salt-sensitive hypertension. Majid DS; Kopkan L Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):946-52. PubMed ID: 17645645 [TBL] [Abstract][Full Text] [Related]
38. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease. Matsuguma K; Ueda S; Yamagishi S; Matsumoto Y; Kaneyuki U; Shibata R; Fujimura T; Matsuoka H; Kimoto M; Kato S; Imaizumi T; Okuda S J Am Soc Nephrol; 2006 Aug; 17(8):2176-83. PubMed ID: 16807406 [TBL] [Abstract][Full Text] [Related]
39. Nitric oxide synthase derangements and hypertension in kidney disease. Baylis C Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):1-6. PubMed ID: 22048724 [TBL] [Abstract][Full Text] [Related]
40. GC-MS measurement of biological N Bollenbach A; Bakker SJL; Tsikas D Amino Acids; 2019 Apr; 51(4):627-640. PubMed ID: 30610471 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]